Tag:
Rex Trueform
Ghost Bites
Ghost Bites (Barloworld | Capital Appreciation | Ethos Capital | Fairvest | Tsogo Sun)
Fairvest's portfolio strategy is working beautifully. Barloworld is having another difficult year, whereas Ethos Capital is having a much better time of things. Tsogo Sun is excited about the casino opportunity in Somerset West. Capital Appreciation has settled the Dariel earn-out after it missed profit targets.
Ghost Bites
Ghost Bites (Burstone | Gemfields | Grand Parade | Remgro)
Remgro's NAV grew solidly this year and they insist on a special dividend instead of more buybacks. Burstone's platform strategy is growing, but perhaps not quickly enough. Gemfields needs things to improve rather urgently. Grand Parade's casino exposure is problematic.
Ghost Bites
Ghost Bites (Afrimat | Bidcorp | Blue Label Telecoms | Curro | OUTsurance | Spur | Transpaco)
Curro is becoming a non-profit organisation - and it all makes perfect sense. OUTsurance is flying. Punters took profit on Blue Label after results. Afrimat and Transpaco are having a tough time. Bidcorp put in a dependable performance. Spur has a legal battle around a rib plant.
Ghost Bites
GHOST BITES (Bell Equipment | Netcare | Novus | Orion Minerals | MultiChoice | Safari Investments | Telkom)
MultiChoice has rug pulled its B-BBEE investors. Bell Equipment is way off its offer price and earnings are dropping. Telkom and Netcare are both growing. Safari Investments is exiting Namibia. Novus and the TRP aren't friends. Orion released its long-awaited DFS for both major assets.
DealMakers
Who’s doing what this week in the South African M&A space?
Weekly summary of Merger & Acquisition activity by South African companies
Ghost Bites
GHOST BITES (AECI | Altvest | Merafe | MTN | Northam Platinum | Primary Health Properties | Sabvest | Safari Investments | Thungela)
Merafe, MTN, Northam Platinum, Primary Health Properties, Sabvest, Safari Investments and Thungela all released numbers. AECI announced a B-BBEE deal. Altvest has raised debt capital in ACOF.
Ghost Bites
GHOST BITES (Aspen | Metair | Rex Trueform | Sanlam | Sasfin)
Aspen is bringing Eli Lilly's Ozempic competitor to the SA market. Metair is getting even less from the Mutlu disposal than we thought. Rex Trueform is buying a software group at a huge multiple. Sanlam unlocked billions from Allianz. Sasfin is delisting this month.
Ghost Bites
GHOST BITES (enX | Grindrod | MAS | NEPI Rockcastle | Sibanye-Stillwater | South32)
EBITDA margins are significantly lower at Grindrod. Sibanye-Stillwater has raised $500 million through a streaming deal in its local PGM mines. South32 is navigating the Mozambique unrest successfully.
